Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
pfizer
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
abbvie
adverum biotechnologies
akcea therapeutics
albert bourla
alzheimer's disease
amgen
amicus therapeutics
anylam pharmaceuticals
archive
artificial intelligence
arvinas
batten disease
bayer
biogen
biotech
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
business
cancer diagnostics
cancer immunotherapy
cardiomyopathy
casimir trials
catalia health
category-/business & industrial/pharmaceuticals & biotech
celenex
christine mcsherry
chuck schumer
clinial trials
What
patients
5
×
pfizer
pfizer’s
covid
drug
home
maker
medicines
acquisitions
advice
ago
akcea
albert
allergic
allergies
alnylam
amyloidosis
analysis
announced
antiviral
appropriate
approved
attr
available
battle
biggest
bio
biontech
bourla
cautious
ceo
chronic
company
crispr
debilitating
disease
earlier
epic
evaluation
experienced
Language
unset
unknown
Current search:
pfizer���s
×
patients
×
@slashgear.com
2 years ago
Pfizer’s “overwhelming” COVID-19 pill results fuel home treatment hopes
@thenextweb.com
3 years ago
The risks of Pfizer’s COVID-19 vaccine for patients with a history of severe allergies
@venturebeat.com
4 years ago
Pfizer launches pilot with home robot Mabu to study patient response to AI
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea